SCHEMBL29615409

SCHEMBL29615409

Clc1nccc2occc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.46
HTR2C P28335 2/20 0.43
TRPA1 O75762 1/20 0.39
MAOA P21397 3/20 0.39
MAOB P27338 3/20 0.39
FTO Q9C0B1 1/20 0.39
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
APEX1 P27695 1/20 0.38
MAPK1 P28482 1/20 0.38
PMP22 Q01453 1/20 0.38
CNR2 P34972 1/20 0.36
DRD1 P21728 5/20 0.36
NFKB1 P19838 1/20 0.33
F2RL3 Q96RI0 1/20 0.33
AURKA O14965 1/20 0.32
KCNA3 P22001 1/20 0.32
DYRK1A Q13627 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127374 1.00 FADS1 (0.46) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL557772 0.73 NOS3 (0.43) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL11625851 0.73 HTR2C (0.43) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL22729154 0.73 HTR2C (0.43) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL16488517 0.73 HTR2C (0.43) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL15688333 0.73 HTR2C (0.43) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL2757287 0.73 HTR2C (0.47) FADS1HTR2CTRPA1CNR2DRD1
SCHEMBL22323315 0.73 TRPA1 (0.46) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL3803166 0.72 HTR2C (0.40) FADS1HTR2CTRPA1MAOAMAOB
SCHEMBL29935606 0.72 HTR2C (0.40) FADS1HTR2CTRPA1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263546-B1 DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARM SPA (IT) 2025-07-02 EP disclosed
CN-115667259-B Fused ring compounds for inhibiting H-PGDS 佐藤制药株式会社 2025-06-17 CN disclosed
CN-115380030-B N-heteroarylalkyl-2- (heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists 武田药品工业株式会社 2025-05-16 CN disclosed
CN-119212988-A Kinesin KIF18A inhibitor and application thereof 上海湃隆生物科技有限公司 2024-12-27 CN disclosed
CN-116368131-B Novel Smad3 protein degradation agent and application thereof 和径医药科技(上海)有限公司 2024-09-20 CN disclosed
CN-116600810-A Dihydrofuranopyridine derivatives as RHO-kinase inhibitors 奇斯药制品公司 2023-08-15 CN disclosed
CN-116568303-A Dihydrofuranopyridine derivatives as RHO-kinase inhibitors 奇斯药制品公司 2023-08-08 CN disclosed
EP-4126848-A1 N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS Takeda Pharmaceutical Company Limited (JP) 2023-02-08 EP disclosed
CN-115667259-A Condensed ring compounds for inhibiting H-PGDS 佐藤制药株式会社 2023-01-31 CN disclosed
CN-108602807-B Heterocyclic sulfonamide derivatives and drugs containing the same EA制药株式会社 2022-05-13 CN disclosed